Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Ariana Grande and Jonathan Bailey will reunite for 'Sunday in the Park With George' - 2Kiefer Sutherland arrested after allegedly assaulting a ride-share driver in L.A.
- 3What's going on with Katseye? The Manon Bannerman hiatus drama, explained.
- 4Reclassifying Achievement: Individual Accounts of Seeking after Interests
- 5Italy fertility rate fell to new low of 1.14 in 2025
- Sean Penn lights up, Kylie Jenner gets A-list approval and 7 other moments you didn’t see at the Golden Globes
- Lego's $650 Pokémon set is already sold out as demand, preorders surge
- Best Internet based Course for Learning Another Dialect: Which Stage Do You Like?
- Excursion to Different Universes: the Top Sci-fi Motion pictures Ever
- 37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- ‘I love this work, but it’s killing me’: The unique toll of being a spiritual leader today
- Israel kidnaps PIJ terrorist in covert op. in Hamas-controlled Gaza in pursuit of Ran Gvili
- Find the Standards of Viable Refereeing: Settling Debates with Strategy
- Quandoo to shut restaurant booking platform by end of 2026
